Sunday, January 04, 2026 4:54:11 AM
Gregory Zivic, MD
@metacollectiveG
$NWBO is behaving like a true Pharma company. The first approval will unleash a landslide of hidden gems that some have been seeing in plain site while FUDSTERS keep most looking directly at them.
Quote
Peter Davis
@peter_brit
·
Jan 3
#dcvax $nwbo #gbm
Linda Powers has this interesting phase 2 trial of CYT-107 due to start on the 6th January, 2026
(See Gemini AI Analysis below especially relating to noteworthy aspects regarding the outcome measures and the design of this trial) :
Recombinant Glycosylated
Show more
11:52 PM · Jan 3, 2026
·
3,332
Views
@metacollectiveG
$NWBO is behaving like a true Pharma company. The first approval will unleash a landslide of hidden gems that some have been seeing in plain site while FUDSTERS keep most looking directly at them.
Quote
Peter Davis
@peter_brit
·
Jan 3
#dcvax $nwbo #gbm
Linda Powers has this interesting phase 2 trial of CYT-107 due to start on the 6th January, 2026
(See Gemini AI Analysis below especially relating to noteworthy aspects regarding the outcome measures and the design of this trial) :
Recombinant Glycosylated
Show more
11:52 PM · Jan 3, 2026
·
3,332
Views
$NWBO is behaving like a true Pharma company. The first approval will unleash a landslide of hidden gems that some have been seeing in plain site while FUDSTERS keep most looking directly at them. https://t.co/epND0S4flA
— Gregory Zivic, MD (@metacollectiveG) January 3, 2026
Bullish
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
